Estrogen helps to regulate bone mass by inhibiting osteoclast activity in the body. During menopause, when levels of estrogen begin to decrease in women, osteoclast activity increases. This biological change puts postmenopausal women at a greater risk of developing osteoporosis, because bone resorption (osteoclast activity) exceeds bone deposition (osteoblast activity).
Glucocorticoids can cause increased bone loss, if used long-term. These medications directly inhibit osteoblast activity and cause increased urinary excretion of calcium. Both of which affect bone mass and formation.
Osteoporosis most commonly affects the vertebral bones. When bones in the spine weaken and fracture over time, patients may develop a humped back, known as kyphosis.
Another name for kyphosis is dowager’s hump. Curvature of the spine occurs when the front portion of the affected vertebra fractures and compresses. Typically, the posterior side of the vertebra is unaffected, causing the spine to tip forward into a curved posture.
Weakening of the bones makes a person more prone to bone fractures. Because osteoporosis commonly affects bones in the spine, repeated bone fractures in this area can lead to gradual loss of height. On average, a person’s height can decrease by two to three inches.
Back pain, especially in the lumbar area, in patients with osteoporosis is usually associated with a spinal fracture.
Weakening of the bones in patients with osteoporosis can cause fractures, unrelated to an injury, especially in the bones of the wrists, upper femur, and pelvis.
Fractures that occur in the spine, causing the vertebral bone to collapse, or compress, are commonly seen in patients with osteoporosis. This type of fracture can be very painful and can eventually lead to kyphosis of the spine.
Picmonic's rapid review multiple-choice quiz allows you to assess your knowledge.
*Average video play time: 2-3 minutes
Unforgettable characters with concise but impactful videos (2-4 min each)